FDA issued recall of Synergy Cranial software and Stealth Station S7 Cranial software by Medtronic due to inaccuracies displayed during surgical procedures.
FDA issued recall of CAmlodipine/Valsartan Tablets USP, Valsartan/HCTZ Tablets, USP and Valsartan Tablets USP by Aurobindo due to NDEA (N-Nitrosodiethylamine) impurity.